Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.57 |
| ▸ | KIF11 | P52732 | 8/20 | 0.47 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | DRD1 | P21728 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5800348 | 0.98 | TAAR1 (0.55) | TAAR1KIF11ENPP2ESR1ESR2 | |
| SCHEMBL2593641 | 0.85 | TAAR1 (0.70) | TAAR1KIF11ESR1ESR2CYP3A4 | |
| SCHEMBL31215161 | 0.82 | LMNA (0.44) | KIF11ESR1ESR2ALDH1A1CA12 | |
| SCHEMBL825377 | 0.82 | LMNA (0.44) | KIF11ESR1ESR2ALDH1A1CA12 | |
| SCHEMBL6027444 | 0.82 | CNR1 (0.46) | KIF11ENPP2ESR1ESR2ALDH1A1 | |
| SCHEMBL3855587 | 0.80 | SHBG (0.59) | KIF11ENPP2ESR1ESR2DRD1 | |
| SCHEMBL22299378 | 0.79 | TAAR1 (0.61) | TAAR1KIF11ESR1ESR2ALDH1A1 | |
| SCHEMBL5648833 | 0.78 | CNR1 (0.43) | KIF11ESR1ESR2ALDH1A1CA12 | |
| SCHEMBL27985669 | 0.78 | KIF11 (0.43) | KIF11ESR1ESR2ALDH1A1CA12 | |
| SCHEMBL3065653 | 0.78 | KIF11 (0.43) | TAAR1KIF11ENPP2ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024150677-A1 | ACTIVE-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION | 富士フイルム株式会社 | 2024-07-18 | — | — | WO | disclosed |
| EP-2054373-A1 | IMPROVED PROCESS FOR THE PREPARATION OF RIVASTIGMINE | Alembic Limited (IN) | 2009-05-06 | — | — | EP | disclosed |
| CN-101277929-A | Method of obtaining phenyl carbamates | INTERQUIM SA (ES) | 2008-10-01 | — | — | CN | disclosed |
| WO-2008020452-A1 | IMPROVED PROCESS FOR THE PREPARATION OF RIVASTIGMINE | ALEMBIC LIMITED (IN) | 2008-02-21 | — | — | WO | disclosed |
| CN-100364961-C | Phenoxyhydrindone derivatives containing nitrogen and preparation and use thereof | UNIV ZHEJIANG (CN) | 2008-01-30 | — | — | CN | disclosed |
| EP-1856036-A1 | AN EFFICIENT METHOD FOR PREPARATION OF (S)-3-[(1-DIMETHYL AMINO)ETHYL]-PHENYL-N-ETHYL-N-METHYL-CARBAMATE | Emcure Pharmaceuticals Limited (IN) | 2007-11-21 | — | — | EP | disclosed |
| US-7259266-B2 | Benzopyran compounds useful for treating inflammatory conditions | PHARMACIA CORPORATION (US) | 2007-08-21 | — | — | US | disclosed |
| WO-2006068386-A1 | SYNTHETIC METHOD OF PHENYLCARBAMATE DERIVATIVE | DONG KOOK PHARM. CO., LTD (KR) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006048720-A1 | AN EFFICIENT METHOD FOR PREPARATION OF (S)-3-[(1-DIMETHYL AMINO)ETHYL]-PHENYL-N-ETHYL-N-METHYL-CARBAMATE | EMCURE PHARMACEUTICALS LIMITED (IN) | 2006-05-11 | — | — | WO | disclosed |
| CN-1768050-A | Benzopyran compounds for the treatment of inflammation | PHARMACIA CORP (US) | 2006-05-03 | — | — | CN | disclosed |
| CN-1680279-A | Phenoxyhydrindone derivatives containing nitrogen and preparation and use thereof | UNIV ZHEJIANG (CN) | 2005-10-12 | — | — | CN | disclosed |
| US-20050148627-A1 | Benzopyran compounds for use in the treatment and prevention of inflammation related conditions | CARTER JEFFERY (US) | 2005-07-07 | — | — | US | disclosed |
| US-20050148777-A1 | Benzopyran compounds useful for treating inflammatory conditions | CARTER JEFFERY (US) | 2005-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050148777-A1 | Benzopyran compounds useful for treating inflammatory conditions | PTGES2, PTGER2, PTGS2 | TAAR1 1061/4885KIF11 4857/4885ENPP2 72/4885 |
| US-20050148627-A1 | Benzopyran compounds for use in the treatment and prevention of inflammation related conditions | PTGES2, PTGER2, PTGES | TAAR1 1035/4885KIF11 4869/4885ENPP2 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.